When was Vivtex founded?

Vivtex was founded in 2018 and raised its 1st funding round 4 years after it was founded.

Where is Vivtex located?

Vivtex is headquartered in Cambridge, United States.

Who is the current CEO of Vivtex?

Douglas Eby of Vivtex. They have also founded 1 company.

How many employees does Vivtex have?

As of Oct 31, 2026, the latest employee count at Vivtex is 27.

Is Vivtex a funded company?

Vivtex is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Aug 19, 2022.

When was the latest funding round of Vivtex?

Vivtex's latest funding was a $***** Seed round on Aug 19, 2022, with participation from 0 investor.

Where does Vivtex rank among its competitors?

Vivtex ranks 4th amongst 72 active competitors, of which 15 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Orbis Medicines, which secured an undisclosed amount in Sep, 2026.

Who are the top competitors of Vivtex?

Vivtex's top competitors include Cure Pharmaceutical, Cingulate and Orbis Medicines. Among them, Orbis Medicines secured the most recent funding round in September, 2026.

Vivtex - 2026 Company Profile, Team, Funding & Competitors

Vivtex is a seed company based in Cambridge (United States), founded in 2018 by C Giovanni Traverso, Douglas Eby, Thomas Von Erlach and Robert Langer. It operates as a Developer of oral drug delivery system. Vivtex has raised $1.8M in funding. The company has 72 active competitors, including 15 funded and 13 that have exited. Its top competitors include companies like Cure Pharmaceutical, Cingulate and Orbis Medicines.

Company Details

Developer of oral drug delivery system. The company is also developing programs that focus on the local delivery of antisense oligonucleotide and plasmid DNA therapeutics into GI tissue for the treatment of GI-related diseases. The Gastrointestinal Organ Robotic Interface System (GI-ORIS) and proprietary algorithms enable real-time automated data reporting and are integrated into the electronic inventory and experimental reporting system.

Website: vivtex.com
Email ID: *****@vivtex.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Cambridge, United States

Stage

Seed

Total Funding

$1.8M in 1 round

Latest Funding Round

Seed, Aug 19, 2022, $*****

Ranked

4^th among 72 active competitors

Employee Count

27 as on Oct 31, 2026

Similar Companies

Genedit & 90 more

View Vivtex's full profile

Vivtex is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
VIVITEX CORPORATION CIN: 830902645 , United States, Active	Apr 26, 2020	-	10 (As on Dec 31, 2022)	-

Vivtex has raised a total funding of $1.8M over 1 round.

Here is the list of recent funding rounds of Vivtex:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 19, 2022	2319818	Seed	5672910	6963604	4444502	9241672

Access funding benchmarks and valuations. Sign up today!

View details of Vivtex's funding rounds and investors

The founders of Vivtex are C Giovanni Traverso, Douglas Eby, Thomas Von Erlach and Robert Langer. Douglas Eby is the CEO of Vivtex.

Here are the details of Vivtex's key team members:

C Giovanni Traverso: Co-Founder of Vivtex and founder of 6 other companies, including Teal Bio, Suono Bio and Celero Systems.
Douglas Eby: Co-Founder & CEO of Vivtex.
Contact Info: 1 email address
Thomas Von Erlach: Co-Founder & CSO of Vivtex.
Robert Langer: Co-Founder of Vivtex.

View details of Vivtex's Founder profiles and Board Members

Vivtex's employee count trend

Vivtex has 27 employees as of Oct 26. Here is Vivtex's employee count trend over the years:

Uncover Vivtex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Vivtex include Cure Pharmaceutical, Cingulate and Orbis Medicines. Here is the list of Top 10 competitors of Vivtex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cure Pharmaceutical 2010, Oxnard (United States), Public	Developer of oral thin film based drug delivery systems	$9.65M	Onbelay Capital, Hangar202 & 1 others	62/100
2nd	Cingulate 2012, Kansas City (United States), Public	Developer of therapeutics for the treatment of ADHD	$33M	The Werth Family Foundation, Lincoln Park Capital ... & 2 others	58/100
3rd	Orbis Medicines 2022, Copenhagen (Denmark), Series A	Provider of drug discovery platform to develop multiple therapeutics	$126M	Novo Holdings, New Enterprise Associates & 5 others	54/100
4th	Vivtex 2018, Cambridge (United States), Seed	Developer of oral drug delivery system	$1.8M	-	56/100
5th	PLx Pharma 2002, Sparta (United States), Public	Developer of drug delivery platform to treat gastrointestinal diseases	$25.3M	Aurus, HHS	52/100
6th	Oramed 2006, Jerusalem (Israel), Public	Developer of oral reformulations to treat various health conditions	-	EIC Fund, Europa	52/100
7th	Ingenus 2010, Orlando (United States), Unfunded	Developer of oral drug delivery and drugs for treating cancer	-	-	49/100
8th	G2GBIO 2017, Yuseong District (South Korea), Public	Developer of sustained release injectables	-	Korea Investment Holdings, BNK Venture Capital ... & 1 others	48/100
9th	ThinSol 2017, Hyderabad (India), Series A	Provider of oral thin strips for bioavailability and discreet administration	$4.59M	Reddy Growth & 8 others	46/100
10th	Lipocine 1997, Salt Lake City (United States), Public	Develops oral versions of hormones using Hydroance drug delivery technology	$38M	Foresite Capital	45/100